Globus Medical, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Globus Medical, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 51.1 times by its yearly operating cash. Higher than 95% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $47 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $46 tied up three years earlier. More money tied up than 90% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
$199Over the last 3 years, every $100 of reported profit came with $199 of operating cash.
Higher than 76% of Healthcare companies in United States.
Self-Funding Ratio
4.1×Over the last 3 years its own operating cash covered its investment spending (capex) 4.1 times.
Higher than 83% of Healthcare companies in United States.
Cash Locked Ratio
$47For every $100 of sales, $47 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $46 tied up three years earlier.
More money tied up than 90% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$18Sales grew 187% in 3 years; of every extra $100 of sales, $18 became extra profit.
Lower than 51% of Healthcare companies in United States.
Asset Productivity Ratio
+187% / +155%In 3 years sales changed by +187% while total assets changed by +155%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
51.1×Debt due within a year is covered 51.1 times by its yearly operating cash.
Higher than 95% of Healthcare companies in United States.
Cash Cushion Ratio
+4%Cash, after subtracting all debt, equals 4% of its market value (net cash).
Lower than 59% of Healthcare companies in United States.
Tangible Assets Ratio
59%Of every $100 the company owns, $59 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 70% of Healthcare companies in United States.
Tangible Net Worth Ratio
52%Of every $100 of net worth, $52 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 51% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Globus Medical, Inc. owes $0.13 for every $1 it owns. Net profit rose 422% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
20.9Investors pay $20.9 for every $1 of Globus Medical, Inc.'s yearly profit, lower than 63% of Healthcare companies in United States.
P/B ratio
2.30The share price is 2.30 times Globus Medical, Inc.'s book value per share, lower than 53% of Healthcare companies in United States.
Market cap
$11.0 BThe total market value of all of Globus Medical, Inc.'s shares at today's price (share price × number of shares), larger than 90% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$4.8 BWhat Globus Medical, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$35.52Net worth divided by the number of shares. The share price of $81.66 is 2.3 times this, which is the P/B above.
Return on equity (ROE)
11.8%Globus Medical, Inc. earned 11.8% on its shareholders' money over the last year, higher than 85% of Healthcare companies in United States.
Owes vs Owns
0.13×Globus Medical, Inc. owes $0.13 for every $1 it owns (low), lower than 81% of Healthcare companies in United States.
Dividend yield
NoneGlobus Medical, Inc. does not currently pay a dividend.
Revenue growth
+17%Revenue rose 17% in the year to Dec 2025, and grew 42% a year on average over 3 years.
Profit growth
+422%Net profit rose 422% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Profit margin
18.3%Globus Medical, Inc. keeps $18 of every $100 of revenue as net profit.
Cash quality
1.4×Cash from Globus Medical, Inc.'s business was 1.4× its reported profit in the year to Dec 2025 — its profit turned into cash.
Cash vs debt
Net cashGlobus Medical, Inc. held $439 M more cash than debt (net cash) at Dec 2025.
Questions
What is Globus Medical, Inc.'s P/E ratio?
Investors pay $20.9 for every $1 of Globus Medical, Inc.'s yearly profit, lower than 63% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Globus Medical, Inc.: $11.0 B ÷ $4.8 B (30 Jun 2026) = 2.3.
What is Globus Medical, Inc.'s return on equity?
Globus Medical, Inc. earned 11.8% on its shareholders' money over the last year, higher than 85% of Healthcare companies in United States.
How much does Globus Medical, Inc. owe compared with what it owns?
Globus Medical, Inc. owes $0.13 for every $1 it owns (low), lower than 81% of Healthcare companies in United States.
Does Globus Medical, Inc. pay a dividend?
No. Globus Medical, Inc. does not currently pay a dividend.
Is Globus Medical, Inc.'s revenue growing?
Revenue rose 17% in the year to Dec 2025, and grew 42% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.